MLchartDataset catalogue

VB4-845

Term · Oncology and biomedicine · MLC-T-ONC-009191

A substance being studied in the treatment of certain types of head and neck cancer. VB4-845 is made by linking a monoclonal antibody fragment to a toxic protein that may kill cancer cells. It binds to EpCAM (a protein on the surface of epithelial cells and some types of cancer cells). Also called anti-EpCAM-Pseudomonas-exotoxin fusion protein and Proxinium.

Table 1. Record
IdentifierMLC-T-ONC-009191
FieldOncology and biomedicine
Expansionsanti-EpCAM-Pseudomonas-exotoxin fusion protein; Proxinium
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-009191",
  "term": "VB4-845",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of certain types of head and neck cancer. VB4-845 is made by linking a monoclonal antibody fragment to a toxic protein that may kill cancer cells. It binds to EpCAM (a protein on the surface of epithelial cells and some types of cancer cells). Also called anti-EpCAM-Pseudomonas-exotoxin fusion protein and Proxinium.",
  "expansions": [
    "anti-EpCAM-Pseudomonas-exotoxin fusion protein",
    "Proxinium"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/vb4-845/"
}

Record 17,148 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.